Demerol Meperidine Companies

ID: MRFR/HC/10535-HCR

128 Pages

Rahul Gotadki

October 2025

Demerol and Meperidine Companies specialize in the production and distribution of pharmaceuticals, with a focus on the opioid analgesic Meperidine, commonly marketed as Demerol. Committed to advancing pain management, these companies adhere to stringent quality standards in manufacturing. They aim to provide effective and safe solutions for healthcare professionals, ensuring patient well-being and comfort.

Demerol Meperidine Market Research Report 2034 Infographic

Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Demerol Meperidine Market

Demerol Meperidine Key Companies

Latest Demerol Meperidine Companies Update:

In December 2023, a study published in the Journal of Pain and Symptom Management found that meperidine offered no significant pain relief advantage compared to other opioids in patients with cancer-related pain. This could potentially further discourage its use in this setting.

News articles from December 2023 report concerns about potential meperidine shortages in some countries due to manufacturing issues. This could impact its availability and access in certain regions.

List of Demerol Meperidine Key companies in the market

Actavis PLC

Sun Pharmaceuticals

Sanofi

Boehringer Ingelheim

Pfizer, Inc.

Janssen Pharmaceuticals, Inc.

Egalet Corporation

Mallinckrodt Pharmaceuticals

Purdue Pharma

Endo Pharmaceuticals Inc.